Newly surfaced data out of Pennsylvania is adding fuel to an already growing fire — and it’s not exactly flattering to the medical establishment that swore everything was perfectly normal here. According to state records, Pennsylvania saw a dramatic surge in insurance reimbursements for puberty blockers billed under a diagnostic code meant for precocious puberty, a rare condition that typically affects much younger children.
Between 2013 and 2024, more than 220 claims for minors ages 10 to 13 were reimbursed using the ICD code E30.1, costing taxpayers over $1.8 million. For context, there were zero such claims in 2012. By 2016, that number had ballooned to 47. Nothing to see here… unless you actually look at the data.
The Department of Justice under the Trump administration has flagged this very billing code as potentially being used to fraudulently secure insurance coverage for sex-rejecting medical interventions — something multiple medical experts say doesn’t pass the smell test. And they’re being polite about it.
Medical professionals note that true precocious puberty is widely understood to occur before age 10. Seeing large numbers of children well past that age receiving blockers under this diagnosis is, to put it mildly, “highly unusual.” One endocrinologist noted he would expect to see such treatment almost exclusively in children eight and younger — not preteens already entering normal puberty.
The data shows a staggering more-than-2100% increase in reimbursements tied to this code between 2013 and 2017 alone, with payouts for minors jumping from just under $35,000 to nearly $787,000 in four years. Even experts say spikes like this might make sense for infectious diseases — not for a rare endocrine disorder that hasn’t suddenly become contagious.
Some doctors were even more direct, stating that children placed on puberty blockers at age 11 or later are far more likely being treated for gender dysphoria, not precocious puberty — and that the diagnosis may have been deliberately misused to mask what was really happening. If that’s true, it suggests billing codes were treated less like medical tools and more like creative writing exercises.
Similar concerns have been raised in other states. Federal investigators flagged major children’s hospitals for sudden spikes in older children being diagnosed with precocious puberty, with no clear medical explanation. In Texas, the state attorney general has already accused providers of falsifying records and manipulating diagnostic codes to get around laws protecting minors — allegations backed by newly uncovered evidence.
The common thread here is accountability — or the lack of it. And that’s exactly why the Trump administration’s focus on rooting out fraud, protecting children, and enforcing the law matters. When ideology collides with medicine and taxpayers are left holding the bill, oversight isn’t “controversial” — it’s necessary.
The good news is that these practices are finally being examined instead of rubber-stamped. Transparency is creeping back in, and with it, a renewed commitment to protecting kids and taxpayers alike. That’s not politics — that’s progress.
